Work Here?
About ODAIA
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$42.2M
Headquarters
Toronto, Canada
Founded
2018
Overview
ODAIA specializes in predictive analytics and commercial insights for the life sciences sector. Its main product, MAPTUAL, is an AI-driven platform that helps pharmaceutical companies connect with healthcare providers (HCPs) more efficiently, ultimately speeding up the process of getting therapies to patients. MAPTUAL has two key components: MAPTUAL Field, which supports sales teams in targeting and engaging HCPs, especially in challenging market conditions, and MAPTUAL Sphere, which provides marketing teams with real-time analytics and future predictions to enhance decision-making. Unlike many competitors, ODAIA focuses on creating meaningful interactions between pharmaceutical companies and HCPs through its human-centric software. The company's goal is to reduce the time it takes for new therapies to reach patients by improving the way pharmaceutical companies engage with healthcare providers.
Simplify's Take
What believers are saying
- ODAIA's partnership with Veeva enhances HCP engagement through real-time predictive insights.
- MAPTUAL automates customer segmentation, allowing rapid market adjustments.
- ODAIA's $34M CAD Series B funding shows strong investor confidence.
What critics are saying
- Generative AI's rapid evolution could outpace ODAIA's current capabilities.
- Integration with Veeva Vault CRM may face technical challenges or delays.
- Reliance on a few large clients poses financial risk if they switch to competitors.
What makes ODAIA unique
- ODAIA combines process mining, customer journey mapping, and AI in its CDP.
- MAPTUAL offers real-time insights for sales and marketing in the life sciences.
- ODAIA's Customer Science integrates AI, data science, and behavioral science.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$42.2M
Below
Industry Average
Funded Over
3 Rounds
Industry standards
Growth & Insights and Company News
6 month growth
↑ 2%1 year growth
↑ 2%2 year growth
↑ 26%ODAIA is first company to join Veeva AI Partner Program and provide industry's first GenAI solution for Veeva Vault CRMCompany to deliver LLM-driven, real-time, predictive insights in Veeva Vault CRM for sales to enhance call planning, pre-call insights, and HCP engagementBOSTON, May 7, 2024 /PRNewswire/ -- Veeva Commercial Summit -- ODAIA today announced it is expanding its product partnership with Veeva Systems , joining the Veeva AI Partner Program to advance the use of Generative AI (GenAI) in life sciences. As the first product partner in the program, ODAIA will deliver an integrated GenAI solution that provides real-time, predictive insights right in Veeva Vault CRM. Sales teams will be able to enhance call planning and pre-call planning to drive more targeted, relevant, timely, and personalized engagement with healthcare professionals (HCPs).The ODAIA platform, MAPTUAL, is the first and only Customer Science cloud for pharma that combines data science and behavioral science with AI and machine learning to gain a deep understanding of HCPs and their patients' journeys. MAPTUAL analyzes vast amounts of data to predict future HCP behavioral trends and prescribing patterns in real time. Innovative companies, including three of the top 15 largest biopharma organizations , use ODAIA to improve HCP targeting and engagement and get treatments to patients faster."GenAI is a new technology that is rapidly evolving. Veeva's strategy is to enable our customers and partners to develop AI solutions that work well with any Veeva Vault application," said Paul Shawah, executive vice president of commercial strategy at Veeva
TORONTO, April 23, 2024 /PRNewswire/ -- Pharma experts and AI innovators from ODAIA will be the featured presenters at top industry events this spring. Speakers will share how pharma companies are advancing their commercial strategies using Customer Science , a transformative discipline that integrates AI with data science and behavioral science for a deeper understanding of healthcare professionals (HCPs) and what motivates their patient decisions.Veeva Commercial Summit , Boston, May 8, at 12:30 p.m. ESTPhilip Poulidis, CEO , will demonstrate the use of AI to find, select, and engage the right HCPs. It typically takes months for marketing to complete customer segmentation and targeting, which is refreshed once or twice a year. When there's a marketplace change, an entirely new data analysis must be done, taking more months before sales gets updated plans of action to start engaging HCPs.Poulidis will show ODAIA MAPTUAL completing this process in minutes, not months. Marketing can set new brand objectives, use advanced AI capabilities to automate data analysis, and deliver personalized GenAI-powered insights in Veeva CRM MyInsights
Life sciences industry experts and software innovators to help pharma companies advance their commercial strategies using Customer ScienceTORONTO, Feb. 6, 2024 /PRNewswire/ -- ODAIA today announced it expanded its strategic alliances, product management, and marketing leadership teams to help address customers' most strategic challenges in commercial operations. The company is bringing together accomplished life sciences industry experts and proven SaaS technology leaders to accelerate innovation and customer success in Customer Science , an emerging business discipline that integrates data science, behavioral science, and AI to drive healthcare professional (HCP) engagement."ODAIA has a tremendous opportunity to help pharmaceutical companies gather insights across many different channels and datasets, and use the power of AI to enhance the HCP experience," said Philip Poulidis , CEO and co-founder at ODAIA. "We're deepening our bench of leaders with strong technology and life sciences backgrounds to advance our pioneering work in Customer Science and help the industry get life-changing therapies to the patients that need them faster."The ODAIA Customer Science cloud solution, MAPTUAL , gives sales and marketing advanced, AI-driven insights and predictions for a comprehensive understanding of HCP prescribing patterns and behavioral trends. Over the past year, ODAIA has added 2 of the largest 15 pharma companies as customers, helping commercial teams spend less time analyzing data and more time engaging the right HCPs.ODAIA continues to attract top talent to drive the next phase of innovation in Customer Science and help advance pharma customers' commercial strategies. Today's news builds upon other recent leadership hires with the addition of the following industry and software veterans and almost 60 years of combined experience in life sciences and B2B technology:Peter Harbin, vice president of industry solutions and strategic alliances – Harbin brings nearly 30 years life sciences industry experience to ODAIA, with expertise in analytics, cloud, business intelligence, and information management
Top independent research firm positions ODAIA as a Major Contenderamong next-generation customer engagement platforms for life sciencesTORONTO, Jan. 17, 2024 /PRNewswire/ -- Cutting-edge AI company, ODAIA , today announced it was named a Major Contender in the Life Sciences Next-generation Customer Engagement Platforms (CEP) PEAK Matrix® Assessment 2023 from Everest Group. As the life sciences industry continues its rapid shift to digital and delivering personalized healthcare professional (HCP) experiences, innovative biopharma companies, including 2 of the top 15 pharma companies, are using ODAIA to give their commercial teams near real-time, predictive data insights to target and engage HCPs and get life-changing therapies to patients faster."Sales planning and targeting takes months so by the time it's done, what HCPs are prescribing can change," said Shea Doughton, commercial operations leader at Acadia Pharmaceuticals. "AI can not only make the planning process more efficient, but also predict trends so our sales teams can decide how best to approach a market segment and enhance HCP engagement. We're excited about the potential of ODAIA helping us get breakthrough neuroscience solutions to patients faster and more effectively."The process of getting treatments to market remains manual and time-consuming for many sales and marketing organizations. ODAIA is helping biopharma companies innovate their commercial strategies using Customer Science, a business discipline that integrates data science, behavioral science, and AI to gain a deep understanding of the HCP and patient experience and what motivates their decisions along the customer journey.The ODAIA platform, MAPTUAL , equips pharma sales and marketing teams with advanced, AI-driven insights and predictions, enabling a comprehensive understanding of physician prescribing patterns and behavioral trends
Emily Melton, Managing Partner of Threshold Ventures and Charles Conn, co-founder and Partner of Monograph Ventures, will join ODAIA’s board.
There are no jobs for ODAIA right now.
Find jobs on Simplify and start your career today
About ODAIA
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$42.2M
Headquarters
Toronto, Canada
Founded
2018
There are no jobs for ODAIA right now.
Find jobs on Simplify and start your career today